| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.08 | 0.7 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.073 | 0.7 |